Bio2 Technologies Enrolls First Vitrium Patient in Cervical Spine Fusion Trial
Bio2 Technologies enrolled the first patient in the Investigational Device Exemption trial of the Vitrium cervical interbody device. Aug 05, 2019
Alphatec Closes Public Stock Offering
Alphatec closed its underwritten public offering of ~12.5MM shares of common stock for $4.60/share, receiving gross proceeds of ~US $57.6MM. Aug 05, 2019
Medicrea Gains FDA Clearance of TULIP GENESIS Top loading Screw
Medicrea received FDA clearance to market the TULIP GENESIS top loading screw, the final element in its UNiD ASI spine surgical planning platform. Aug 02, 2019
Centric Medical Launches TARSA-LINK Stand-Alone Wedge Fixation Study
Centric Medical initiated a clinical study of the TARSA-LINK Stand-Alone Wedge Fixation System. Aug 02, 2019
Globus Medical Acquires StelKast, Hip and Knee Device Company
Globus Medical (GMED) acquired StelKast, manufacturer of implants and instruments for hip and knee replacement, for USD $24.1MM in cash plus potentially $4.3MM in product sales milestones. GMED plans to release a robotic system for joint reconstruction in late 2020. Aug 02, 2019
LimaCorporate Enters Distribution Agreement with G21
LimaCorporate completed an agreement to distribute G21's SpaceFlex Cement Spacer portfolio in the European Economic Area, Switzerland, Australia and New Zealand markets. Aug 02, 2019
Nanovis Launches FortiCore Interbodies with New Nanosurface Technology
Nanovis launched FortiCore® interbody fusion devices with a bioceramic nanotube-enhanced surface. Aug 01, 2019
SeaSpine Launches Shoreline RT Cervical Interbody with Reef Topography
SeaSpine commenced limited launch of the Shoreline RT Cervical Interbody Implant featuring Reef Topography for increased surface area. Aug 01, 2019
SeaSpine Launches Mariner Outrigger® Revision System
SeaSpine commenced limited launch of the Mariner® Outrigger® Revision System, an adjunct to Mariner Posterior Fixation. Jul 31, 2019
Alphatec Announces Public Offering of Common Stock
Alphatec announced an underwritten public offering of 10.9MM shares of common stock at a price of USD $4.60/share. Net proceeds will support general corporate purposes. Jul 31, 2019
